세계의 아르테수네이트 정제 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Artesunate Tablet was estimated to be worth US$ 118 million in 2024 and is forecast to a readjusted size of US$ 177 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Artesunate Tablet cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Artesunate tablets are driven by several factors. Firstly, the global malaria control situation remains severe, especially in sub-Saharan Africa and Southeast Asia, where the incidence of malaria remains high, driving the demand for effective antimalarial drugs. Secondly, the efficacy and safety of artesunate tablets in treating malaria make them a priority choice for government procurement. Additionally, with increased international aid efforts, the market coverage of artesunate tablets continues to expand. In summary, artesunate tablets have a broad market prospect globally, attracting the attention and investment of many pharmaceutical companies.In 2024, global Artesunate tablets production reached approximately 39.5 m units, with an average global market price of around US$ 3 perunit.

Despite the broad market prospects of artesunate tablets, they also face some challenges and risks. Firstly, the global malaria control situation is complex and changeable, with severe malaria transmission in some regions, posing certain difficulties for the promotion of artesunate tablets. Secondly, the production cost of artesunate tablets is relatively high, especially in terms of raw material procurement and production processes, which may affect their market competitiveness. Additionally, in some regions, the awareness of artesunate tablets is relatively low, making promotion more challenging. Therefore, enterprises need to fully consider these challenges and risks when formulating market strategies and take corresponding measures to cope.

The downstream demand for artesunate tablets mainly comes from government procurement and international aid projects. With the increasing global emphasis on malaria control, the demand for artesunate tablets continues to grow. Additionally, private medical institutions and non-governmental organizations in some regions have also become important demanders of artesunate tablets. Overall, the downstream demand for artesunate tablets is becoming more diversified, with huge market potential.

The main raw material for artesunate tablets is artemisinin, which mainly comes from the cultivation of Artemisia annua. In recent years, the planting area of Artemisia annua has gradually expanded, ensuring the supply of raw materials for artesunate tablets. However, the cultivation of Artemisia annua is affected by factors such as climate and land, which may lead to instability in supply. Therefore, enterprises need to strengthen cooperation with planting bases in raw material procurement to ensure stable supply.

This report aims to provide a comprehensive presentation of the global market for Artesunate Tablet, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artesunate Tablet by region & country, by Type, and by Application.

The Artesunate Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artesunate Tablet.

Market Segmentation

By Company

• Fosun Pharma (Guilin)
• Ipca Laboratories
• Sanofi Aventis
• Ajanta Pharma
• Shin Poong
• Cipla
• Acino
• MCW Healthcare
• Amivas
• Zydus Cadila

Segment by Type

• Monoaromatic Artesunate
• Compound Artesunate

Segment by Application

• Hospital
• Clinic
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Artesunate Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Artesunate Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Artesunate Tablet in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Artesunate Tablet Product Introduction
• 1.2 Global Artesunate Tablet Market Size Forecast
  • 1.2.1 Global Artesunate Tablet Sales Value (2020-2031)
  • 1.2.2 Global Artesunate Tablet Sales Volume (2020-2031)
  • 1.2.3 Global Artesunate Tablet Sales Price (2020-2031)
• 1.3 Artesunate Tablet Market Trends & Drivers
  • 1.3.1 Artesunate Tablet Industry Trends
  • 1.3.2 Artesunate Tablet Market Drivers & Opportunity
  • 1.3.3 Artesunate Tablet Market Challenges
  • 1.3.4 Artesunate Tablet Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Artesunate Tablet Players Revenue Ranking (2024)
• 2.2 Global Artesunate Tablet Revenue by Company (2020-2025)
• 2.3 Global Artesunate Tablet Players Sales Volume Ranking (2024)
• 2.4 Global Artesunate Tablet Sales Volume by Company Players (2020-2025)
• 2.5 Global Artesunate Tablet Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Artesunate Tablet Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Artesunate Tablet Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Artesunate Tablet
• 2.9 Artesunate Tablet Market Competitive Analysis
  • 2.9.1 Artesunate Tablet Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Artesunate Tablet Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Tablet as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Monoaromatic Artesunate
  • 3.1.2 Compound Artesunate
• 3.2 Global Artesunate Tablet Sales Value by Type
  • 3.2.1 Global Artesunate Tablet Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Artesunate Tablet Sales Value, by Type (2020-2031)
  • 3.2.3 Global Artesunate Tablet Sales Value, by Type (%) (2020-2031)
• 3.3 Global Artesunate Tablet Sales Volume by Type
  • 3.3.1 Global Artesunate Tablet Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Artesunate Tablet Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Artesunate Tablet Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Artesunate Tablet Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Others
• 4.2 Global Artesunate Tablet Sales Value by Application
  • 4.2.1 Global Artesunate Tablet Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Artesunate Tablet Sales Value, by Application (2020-2031)
  • 4.2.3 Global Artesunate Tablet Sales Value, by Application (%) (2020-2031)
• 4.3 Global Artesunate Tablet Sales Volume by Application
  • 4.3.1 Global Artesunate Tablet Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Artesunate Tablet Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Artesunate Tablet Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Artesunate Tablet Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Artesunate Tablet Sales Value by Region
  • 5.1.1 Global Artesunate Tablet Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Artesunate Tablet Sales Value by Region (2020-2025)
  • 5.1.3 Global Artesunate Tablet Sales Value by Region (2026-2031)
  • 5.1.4 Global Artesunate Tablet Sales Value by Region (%), (2020-2031)
• 5.2 Global Artesunate Tablet Sales Volume by Region
  • 5.2.1 Global Artesunate Tablet Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Artesunate Tablet Sales Volume by Region (2020-2025)
  • 5.2.3 Global Artesunate Tablet Sales Volume by Region (2026-2031)
  • 5.2.4 Global Artesunate Tablet Sales Volume by Region (%), (2020-2031)
• 5.3 Global Artesunate Tablet Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Artesunate Tablet Sales Value, 2020-2031
  • 5.4.2 North America Artesunate Tablet Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Artesunate Tablet Sales Value, 2020-2031
  • 5.5.2 Europe Artesunate Tablet Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Artesunate Tablet Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Artesunate Tablet Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Artesunate Tablet Sales Value, 2020-2031
  • 5.7.2 South America Artesunate Tablet Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Artesunate Tablet Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Artesunate Tablet Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Artesunate Tablet Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Artesunate Tablet Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Artesunate Tablet Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Artesunate Tablet Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Artesunate Tablet Sales Value, 2020-2031
  • 6.3.2 United States Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Artesunate Tablet Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Artesunate Tablet Sales Value, 2020-2031
  • 6.4.2 Europe Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Artesunate Tablet Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Artesunate Tablet Sales Value, 2020-2031
  • 6.5.2 China Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Artesunate Tablet Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Artesunate Tablet Sales Value, 2020-2031
  • 6.6.2 Japan Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Artesunate Tablet Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Artesunate Tablet Sales Value, 2020-2031
  • 6.7.2 South Korea Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Artesunate Tablet Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Artesunate Tablet Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Artesunate Tablet Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Artesunate Tablet Sales Value, 2020-2031
  • 6.9.2 India Artesunate Tablet Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Artesunate Tablet Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Fosun Pharma (Guilin)
  • 7.1.1 Fosun Pharma (Guilin) Company Information
  • 7.1.2 Fosun Pharma (Guilin) Introduction and Business Overview
  • 7.1.3 Fosun Pharma (Guilin) Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Fosun Pharma (Guilin) Artesunate Tablet Product Offerings
  • 7.1.5 Fosun Pharma (Guilin) Recent Development
• 7.2 Ipca Laboratories
  • 7.2.1 Ipca Laboratories Company Information
  • 7.2.2 Ipca Laboratories Introduction and Business Overview
  • 7.2.3 Ipca Laboratories Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Ipca Laboratories Artesunate Tablet Product Offerings
  • 7.2.5 Ipca Laboratories Recent Development
• 7.3 Sanofi Aventis
  • 7.3.1 Sanofi Aventis Company Information
  • 7.3.2 Sanofi Aventis Introduction and Business Overview
  • 7.3.3 Sanofi Aventis Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Sanofi Aventis Artesunate Tablet Product Offerings
  • 7.3.5 Sanofi Aventis Recent Development
• 7.4 Ajanta Pharma
  • 7.4.1 Ajanta Pharma Company Information
  • 7.4.2 Ajanta Pharma Introduction and Business Overview
  • 7.4.3 Ajanta Pharma Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Ajanta Pharma Artesunate Tablet Product Offerings
  • 7.4.5 Ajanta Pharma Recent Development
• 7.5 Shin Poong
  • 7.5.1 Shin Poong Company Information
  • 7.5.2 Shin Poong Introduction and Business Overview
  • 7.5.3 Shin Poong Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Shin Poong Artesunate Tablet Product Offerings
  • 7.5.5 Shin Poong Recent Development
• 7.6 Cipla
  • 7.6.1 Cipla Company Information
  • 7.6.2 Cipla Introduction and Business Overview
  • 7.6.3 Cipla Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Cipla Artesunate Tablet Product Offerings
  • 7.6.5 Cipla Recent Development
• 7.7 Acino
  • 7.7.1 Acino Company Information
  • 7.7.2 Acino Introduction and Business Overview
  • 7.7.3 Acino Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Acino Artesunate Tablet Product Offerings
  • 7.7.5 Acino Recent Development
• 7.8 MCW Healthcare
  • 7.8.1 MCW Healthcare Company Information
  • 7.8.2 MCW Healthcare Introduction and Business Overview
  • 7.8.3 MCW Healthcare Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 MCW Healthcare Artesunate Tablet Product Offerings
  • 7.8.5 MCW Healthcare Recent Development
• 7.9 Amivas
  • 7.9.1 Amivas Company Information
  • 7.9.2 Amivas Introduction and Business Overview
  • 7.9.3 Amivas Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Amivas Artesunate Tablet Product Offerings
  • 7.9.5 Amivas Recent Development
• 7.10 Zydus Cadila
  • 7.10.1 Zydus Cadila Company Information
  • 7.10.2 Zydus Cadila Introduction and Business Overview
  • 7.10.3 Zydus Cadila Artesunate Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Zydus Cadila Artesunate Tablet Product Offerings
  • 7.10.5 Zydus Cadila Recent Development

8 Industry Chain Analysis

• 8.1 Artesunate Tablet Industrial Chain
• 8.2 Artesunate Tablet Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Artesunate Tablet Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Artesunate Tablet Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer